127 related articles for article (PubMed ID: 35940519)
61. Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques.
Hartmann L; Biggerstaff JS; Chapman DB; Scott JM; Johnson KR; Ghirardelli KM; Fritschle WK; Martinez DL; Bennington RK; de Baca ME; Wells DA; Loken MR; Zehentner BK
Am J Clin Pathol; 2011 Nov; 136(5):712-20. PubMed ID: 22031309
[TBL] [Abstract][Full Text] [Related]
62. Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin.
Chang H; Wechalekar A; Li L; Reece D
Cancer Genet Cytogenet; 2004 Jan; 148(1):44-8. PubMed ID: 14697640
[TBL] [Abstract][Full Text] [Related]
63. Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.
Oh S; Koo DH; Kwon MJ; Kim K; Suh C; Min CK; Yoon SS; Shin HJ; Jo DY; Kwak JY; Kim JS; Sohn SK; Joo YD; Eom HS; Kim SH; Kim YS; Kim C; Mun YC; Kim H; Lee DS; Lee JH;
Ann Hematol; 2014 Aug; 93(8):1353-61. PubMed ID: 24671365
[TBL] [Abstract][Full Text] [Related]
64. High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation.
Nilsson T; Lenhoff S; Rylander L; Höglund M; Turesson I; Mitelman F; Westin J; Johansson B
Br J Haematol; 2004 Aug; 126(4):487-94. PubMed ID: 15287940
[TBL] [Abstract][Full Text] [Related]
65. MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes.
Yamamoto K; Yakushijin K; Ito M; Goto H; Higashime A; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
Cancer Genet; 2020 Apr; 242():35-40. PubMed ID: 32035866
[TBL] [Abstract][Full Text] [Related]
66. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
[TBL] [Abstract][Full Text] [Related]
67. Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.
Kadam Amare PS; Jain H; Nikalje S; Sengar M; Menon H; Inamdar N; Subramanian PG; Gujral S; Shet T; Epari S; Nair R
Indian J Med Res; 2016 Oct; 144(4):536-543. PubMed ID: 28256461
[TBL] [Abstract][Full Text] [Related]
68. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
Wiktor A; Van Dyke DL
Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
[TBL] [Abstract][Full Text] [Related]
69. A practical approach to the detection of prognostically significant genomic aberrations in multiple myeloma.
Chen Z; Issa B; Huang S; Aston E; Xu J; Yu M; Brothman AR; Glenn M
J Mol Diagn; 2005 Nov; 7(5):560-5. PubMed ID: 16258153
[TBL] [Abstract][Full Text] [Related]
70. Can genome array screening replace FISH as a front-line test in multiple myeloma?
Boneva T; Brazma D; Gancheva K; Howard-Reeves J; Raynov J; Grace C; Nacheva EP
Genes Chromosomes Cancer; 2014 Aug; 53(8):676-92. PubMed ID: 24757046
[TBL] [Abstract][Full Text] [Related]
71. Detection of chromosomal abnormalities in uterine leiomyoma using conventional cytogenetic method and interphase fluorescence in situ hybridization.
Hayashi S; Miharu N; Okamoto E; Samura O; Hara T; Ohama K
Cancer Genet Cytogenet; 1996 Jul; 89(2):98-104. PubMed ID: 8697434
[TBL] [Abstract][Full Text] [Related]
72. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
[TBL] [Abstract][Full Text] [Related]
73. Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement.
Kim S; Kim H; Kang H; Kim J; Eom H; Kim T; Yoon SS; Suh C; Lee D;
J Hematol Oncol; 2013 Oct; 6():76. PubMed ID: 24220305
[TBL] [Abstract][Full Text] [Related]
74. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.
Schmidt-Hieber M; Gutiérrez ML; Pérez-Andrés M; Paiva B; Rasillo A; Tabernero MD; Sayagués JM; Lopez A; Bárcena P; Sanchez ML; Gutiérrez NC; San Miguel JF; Orfao A
Haematologica; 2013 Feb; 98(2):279-87. PubMed ID: 22929983
[TBL] [Abstract][Full Text] [Related]
75. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping.
Veldman T; Vignon C; Schröck E; Rowley JD; Ried T
Nat Genet; 1997 Apr; 15(4):406-10. PubMed ID: 9090389
[TBL] [Abstract][Full Text] [Related]
76. Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma.
Hose D; Rème T; Hielscher T; Moreaux J; Messner T; Seckinger A; Benner A; Shaughnessy JD; Barlogie B; Zhou Y; Hillengass J; Bertsch U; Neben K; Möhler T; Rossi JF; Jauch A; Klein B; Goldschmidt H
Haematologica; 2011 Jan; 96(1):87-95. PubMed ID: 20884712
[TBL] [Abstract][Full Text] [Related]
77. New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
Stella F; Pedrazzini E; Rodríguez A; Baialardo E; Kusminsky G; Arbelbide J; Fantl DB; Slavutsky I
Cytogenet Genome Res; 2011; 134(4):249-59. PubMed ID: 21734361
[TBL] [Abstract][Full Text] [Related]
78. Fluorescence In situ hybridization (FISH) as a tool for the detection of significant chromosomal abnormalities in childhood leukaemia.
Konn ZJ; Wright SL; Barber KE; Harrison CJ
Methods Mol Biol; 2009; 538():29-55. PubMed ID: 19277578
[TBL] [Abstract][Full Text] [Related]
79. [Application of FICTION technique to the detection of genetic aberrations in multiple myeloma].
Wang D; Huang L; Zhang H; Geng Z; Shang Z; Zhou JF; Li CR
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):226-30. PubMed ID: 21569703
[TBL] [Abstract][Full Text] [Related]
80. Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis.
Soekojo CY; Wang GM; Chen Y; Casan J; Wolyncewicz G; Lin A; Poon LM; de Mel S; Koh LP; Tan LK; Ooi MG; Nagarajan C; Liu Y; Lai YY; Huang XJ; Spencer A; Gopalakrishnan SK; Lu J; Chng WJ
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e470-e477. PubMed ID: 31171473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]